PRVB
Income statement / Annual
Last year (2022), Provention Bio, Inc.'s total revenue was $12.90 M,
an increase of 824.37% from the previous year.
In 2022, Provention Bio, Inc.'s net income was -$113.57 M.
See Provention Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$12.90 M |
$1.40 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$512,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$12.38 M
|
$1.40 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.96
|
1
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$75.80 M
|
$69.63 M
|
$66.36 M
|
$36.36 M
|
$22.65 M
|
$7.68 M
|
| General & Administrative Expenses |
$64.11 M
|
$47.35 M
|
$33.33 M
|
$8.01 M
|
$4.17 M
|
$1.46 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$64.11 M
|
$47.35 M
|
$33.33 M
|
$8.01 M
|
$4.17 M
|
$1.46 M
|
| Other Expenses |
$627,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$140.54 M
|
$116.97 M
|
$99.69 M
|
$44.37 M
|
$26.81 M
|
$9.14 M
|
| Cost And Expenses |
$141.06 M
|
$116.97 M
|
$99.69 M
|
$44.37 M
|
$26.81 M
|
$9.14 M
|
| Interest Income |
$2.24 M
|
$146,000.00
|
$583,000.00
|
$1.09 M
|
$669,000.00
|
$131,501.00
|
| Interest Expense |
$1.04 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$3.47 M
|
$387,000.00
|
$33,000.00
|
-$16,000.00
|
$149,000.00
|
$6,501.00
|
| EBITDA |
-$124.69 M |
-$115.58 M |
-$99.69 M |
-$44.37 M |
-$26.67 M |
-$9.13 M |
| EBITDA Ratio |
-9.67
|
-82.85
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-9.94
|
-82.85
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.20 M
|
$146,000.00
|
$583,000.00
|
$1.09 M
|
$149,000.00
|
$6,501.00
|
| Income Before Tax |
-$126.96 M
|
-$115.43 M
|
-$99.10 M
|
-$43.29 M
|
-$26.67 M
|
-$9.13 M
|
| Income Before Tax Ratio |
-9.85
|
-82.75
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$13.39 M
|
-$1.00 M
|
-$523,000.00
|
-$1.09 M
|
-$187,000.00
|
-$131,501.00
|
| Net Income |
-$113.57 M
|
-$114.43 M
|
-$98.58 M
|
-$42.20 M
|
-$26.48 M
|
-$9.13 M
|
| Net Income Ratio |
-8.81
|
-82.03
|
0
|
0
|
0
|
0
|
| EPS |
-1.52 |
-1.81 |
-1.88 |
-1.04 |
-1.18 |
-0.27 |
| EPS Diluted |
-1.52 |
-1.81 |
-1.88 |
-1.04 |
-1.18 |
-0.27 |
| Weighted Average Shares Out |
$74.72 M
|
$63.10 M
|
$52.46 M
|
$40.75 M
|
$22.44 M
|
$33.88 M
|
| Weighted Average Shares Out Diluted |
$74.72 M
|
$63.10 M
|
$52.46 M
|
$40.75 M
|
$22.44 M
|
$33.88 M
|
| Link |
|
|
|
|
|
|
